Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 489

1.

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A.

J Neurol Sci. 1996 Nov;143(1-2):1-13.

PMID:
8981292
4.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

5.

Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.

Sivenius J, Cunha L, Diener HC, Forbes C, Laakso M, Lowenthal A, Smets P, Riekkinen P Sr.

Acta Neurol Scand. 1999 Jan;99(1):54-60.

PMID:
9925239
6.
8.
9.

Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke.

Douen AG, Medic S, Sabih M, Pageau N, Shuaib A.

J Stroke Cerebrovasc Dis. 2008 Nov-Dec;17(6):356-9. doi: 10.1016/j.jstrokecerebrovasdis.2008.04.003.

PMID:
18984426
10.

[Does early high dosage dipyridamole in prevention of secondary stroke induce cardiac events?].

Diener HC, Darius H, Bertrand-Hardy JM, Humphreys M.

Z Kardiol. 2001 May;90(5):348-51. German.

PMID:
11452896
11.
12.

Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS).

Sivenius J, Riekkinen PJ, Kilpeläinen H, Laakso M, Penttilä I.

Acta Neurol Scand. 1991 Oct;84(4):286-90.

PMID:
1772001
13.

Aggrenox: a fixed-dose combination of aspirin and dipyridamole.

Lenz TL, Hilleman DE.

Ann Pharmacother. 2000 Nov;34(11):1283-90. Review.

PMID:
11098344
14.

European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly.

Sivenius J, Riekkinen PJ, Laakso M, Smets P, Lowenthal A.

Acta Neurol Scand. 1993 Feb;87(2):111-4.

PMID:
8442393
15.

Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks.

Matías-Guiu J, Dávalos A, Picó M, Monasterio J, Vilaseca J, Codina A.

Acta Neurol Scand. 1987 Dec;76(6):413-21.

PMID:
3324618
16.

Risk factors and antiplatelet therapy in TIA and stroke patients.

Puranen J, Laakso M, Riekkinen P Sr, Sivenius J.

J Neurol Sci. 1998 Feb 5;154(2):200-4.

PMID:
9562311
17.

ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?

Rouhl RP, Lodder J.

Expert Rev Neurother. 2008 Nov;8(11):1661-5. doi: 10.1586/14737175.8.11.1661. Review.

PMID:
18986236
18.
19.

Dose titration to reduce dipyridamole-related headache.

Chang YJ, Ryu SJ, Lee TH.

Cerebrovasc Dis. 2006;22(4):258-62. Epub 2006 Jun 20.

PMID:
16788299
20.

Secondary prevention of stroke: does dipyridamole add to aspirin?

Lowenthal A, Buyse M.

Acta Neurol Belg. 1994;94(1):24-34.

PMID:
8140884
Items per page

Supplemental Content

Write to the Help Desk